Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6051
Usana Health Sciences
USNA
$238M
| $1.18M | ﹤0.01% |
18,647
-21,149
| -53% | -$1.35M |
|
6052
PUT
Viridian Therapeutics
VRDN
$2.62B
| $1.18M | ﹤0.01% |
49,400
+45,700
| +1,235% | +$1.17M |
|
6053
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$625M
| $1.17M | ﹤0.01% |
22,942
-2,392
| -9% | -$115K |
|
6054
PUT
Buckle
BKE
$2.23B
| $1.17M | ﹤0.01% |
33,900
-17,200
| -34% | -$577K |
|
6055
CALL
Schwab Short-Term US Treasury ETF
SCHO
$13B
| $1.17M | ﹤0.01% |
48,800
-36,000
| -42% | -$873K |
|
6056
iShares US Oil Equipment & Services ETF
IEZ
$394M
| $1.17M | ﹤0.01% |
58,274
-66,408
| -53% | -$1.26M |
|
6057
PUT
inTEST
INTT
$180M
| $1.17M | ﹤0.01% |
44,600
+30,900
| +226% | +$681K |
|
6058
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$111M
| $1.17M | ﹤0.01% |
34,815
+15,386
| +79% | +$503K |
|
6059
CALL
First Trust Cloud Computing ETF
SKYY
$3.31B
| $1.17M | ﹤0.01% |
15,400
-10,200
| -40% | -$701K |
|
6060
CALL
Woodside Energy
WDS
$44.9B
| $1.17M | ﹤0.01% |
50,412
-6,280
| -11% | -$144K |
|
6061
CALL
Toro Company
TTC
$9.28B
| $1.17M | ﹤0.01% |
11,500
-2,000
| -15% | -$205K |
|
6062
Altimmune
ALT
$584M
| $1.17M | ﹤0.01% |
330,829
-1,713,656
| -84% | -$7.69M |
|
6063
Janus International
JBI
$697M
| $1.17M | ﹤0.01% |
109,552
-156,419
| -59% | -$1.46M |
|
6064
Analog Devices
ADI
$190B
| $1.17M | ﹤0.01% |
5,993
+5,822
| +3,405% | +$1.08M |
|
6065
CALL
Cedar Fair
FUN
$1.6B
| $1.17M | ﹤0.01% |
29,200
+4,600
| +19% | +$196K |
|
6066
CALL
Amylyx Pharmaceuticals
AMLX
$2.39B
| $1.17M | ﹤0.01% |
54,100
-44,900
| -45% | -$1.21M |
|
6067
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.71B
| $1.17M | ﹤0.01% |
72,022
+57,399
| +393% | +$939K |
|
6068
CALL
JELD-WEN Holding
JELD
$162M
| $1.17M | ﹤0.01% |
66,500
+43,700
| +192% | +$609K |
|
6069
CALL
Sibanye-Stillwater
SBSW
$7.76B
| $1.17M | ﹤0.01% |
186,900
+122,000
| +188% | +$962K |
|
6070
Invesco S&P 500 Downside Hedged ETF
PHDG
$62.6M
| $1.17M | ﹤0.01% |
+34,979
| New | +$1.15M |
|
6071
OR Royalties Inc
OR
$6.24B
| $1.17M | ﹤0.01% |
75,802
+74,712
| +6,854% | +$1.21M |
|
6072
iShares Russell 3000 ETF
IWV
$20.4B
| $1.16M | ﹤0.01% |
4,577
-14,729
| -76% | -$3.54M |
|
|
OBE
6073
Obsidian Energy
OBE
$772M
| $1.16M | ﹤0.01% |
199,764
-56,673
| -22% | -$351K |
|
|
HIMX
6074
PUT
Himax Technologies
HIMX
$2.69B
| $1.16M | ﹤0.01% |
172,500
+18,500
| +12% | +$130K |
|
6075
CALL
Krystal Biotech
KRYS
$9.94B
| $1.16M | ﹤0.01% |
9,900
-1,300
| -12% | -$133K |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.